• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征并不能比标准风险指标更好地预测5年心血管疾病和全因死亡率。基于人群的前瞻性研究。

Metabolic syndrome does not improve the prediction of 5-year cardiovascular disease and total mortality over standard risk markers. Prospective population based study.

作者信息

López-Suárez Alejandro, Bascuñana-Quirell Antonio, Beltrán-Robles Manuel, Elvira-González Javier, Fernández-Palacín Fernando, Barroso-Casamitjana Elisa, Solino-Ocaña Isabel

机构信息

From the Internal Medicine Department, Virgen del Camino Hospital, Carretera de Chipiona, Sanlúcar de Barrameda, Cádiz, Spain (ALS, ABQ, MBR, JEG, EBC, ISO); and Statistic and Operative Research, Faculty of Sciences, University of Cdiz, Avda. República Saharaui s/n, Puerto Real, Cádiz, Spain (FFP).

出版信息

Medicine (Baltimore). 2014 Dec;93(27):e212. doi: 10.1097/MD.0000000000000212.

DOI:10.1097/MD.0000000000000212
PMID:25501079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4602819/
Abstract

Metabolic syndrome (MS) is widely believed to be an important risk factor for cardiovascular disease (CVD). We assessed whether a model based on MS improved prediction of CVD and total mortality over the Framingham's general CVD system (FRS) and whether MS was better than its individual components. Prospective cohort study of 855 participants randomly selected from the general population. Cox proportional hazards models were used to estimate the hazard ratios selecting a composite endpoint of CVD and total mortality. The performance of the FRS was compared with that of 4 MS-based models that differed in their use of individual components of MS as well as in the use of optimized cut-points of MS. The assessment included metrics of discrimination, calibration, and risk reclassification. Of all the models, only the model containing the 5 optimized components of MS improved model fit (deviance 10.7, P = 0.005), discrimination (difference of areas under the receiving operating curves 0.018), and risk reclassification in participants without events (net reclassification index 5.97, P = 0.01). The addition of optimized waist circumference to the FRS model improved the performance more than any other MS-based model. Every model containing the dichotomous definition of MS failed to improve model fit, discrimination, and risk reclassification. MS did not contribute predictive information over the FRS for the 5-year risk of CVD and total mortality. Some individual components of MS, in particular waist circumference, might play a role as part of the FRS provided their cut-off points are optimized.

摘要

代谢综合征(MS)被广泛认为是心血管疾病(CVD)的一个重要危险因素。我们评估了基于MS的模型是否比弗雷明汉一般心血管疾病系统(FRS)能更好地预测CVD和全因死亡率,以及MS是否比其各个组成部分更具优势。对从普通人群中随机选取的855名参与者进行了前瞻性队列研究。采用Cox比例风险模型来估计风险比,选取CVD和全因死亡率的复合终点。将FRS的性能与4个基于MS的模型进行比较,这些模型在MS各个组成部分的使用以及MS优化切点的使用上存在差异。评估包括区分度、校准度和风险重新分类等指标。在所有模型中,只有包含MS 5个优化组成部分的模型改善了模型拟合度(偏差10.7,P = 0.005)、区分度(受试者工作特征曲线下面积差异0.018)以及无事件参与者的风险重新分类(净重新分类指数5.97,P = 0.01)。在FRS模型中加入优化的腰围比任何其他基于MS的模型更能改善性能。每个包含MS二分定义的模型都未能改善模型拟合度、区分度和风险重新分类。对于CVD和全因死亡率的5年风险,MS并没有比FRS提供更多的预测信息。MS的一些个别组成部分,特别是腰围,如果其切点经过优化,可能作为FRS的一部分发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d0/4602819/701f90983687/medi-93-e212-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d0/4602819/701f90983687/medi-93-e212-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d0/4602819/701f90983687/medi-93-e212-g005.jpg

相似文献

1
Metabolic syndrome does not improve the prediction of 5-year cardiovascular disease and total mortality over standard risk markers. Prospective population based study.代谢综合征并不能比标准风险指标更好地预测5年心血管疾病和全因死亡率。基于人群的前瞻性研究。
Medicine (Baltimore). 2014 Dec;93(27):e212. doi: 10.1097/MD.0000000000000212.
2
3
[Impact of place of residence on the presentation of cardiovascular events and all-cause mortality in a cohort with metabolic syndrome].[居住地对代谢综合征队列中心血管事件发生情况及全因死亡率的影响]
Rev Esp Salud Publica. 2018 Sep 26;92:e201809069.
4
[A comparison between the metabolic syndrome score and the Framingham risk score in the prediction of cardiovascular disease].[代谢综合征评分与弗雷明汉风险评分在预测心血管疾病方面的比较]
Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Feb;31(2):208-12.
5
6
Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.常规 FDG PET/CT 图像上的动脉活性测量可提高对未来心血管事件风险的预测。
JACC Cardiovasc Imaging. 2013 Dec;6(12):1250-9. doi: 10.1016/j.jcmg.2013.08.006. Epub 2013 Oct 23.
7
Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.皮肤自发荧光、动脉僵硬度和弗雷明汉风险评分预测慢性肾脏病患者临床转归的队列研究。
Nephrol Dial Transplant. 2019 Mar 1;34(3):442-448. doi: 10.1093/ndt/gfx371.
8
Do the 2017 blood pressure cut-offs improve 10-year cardiovascular disease mortality risk prediction?2017 年血压切点是否改善了 10 年心血管疾病死亡风险预测?
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):2008-2016. doi: 10.1016/j.numecd.2020.06.017. Epub 2020 Jun 26.
9
Appropriate cut-off values of waist circumference to predict cardiovascular outcomes: 7-year follow-up in an Iranian population.预测心血管结局的腰围适宜截断值:伊朗人群的7年随访
Intern Med. 2012;51(2):139-46. doi: 10.2169/internalmedicine.51.6132. Epub 2012 Jan 15.
10
Non-linear contribution of glucose measures to cardiovascular diseases and mortality: reclassifying the Framingham's risk categories: a decade follow-up from the Tehran lipid and glucose study.葡萄糖指标对心血管疾病和死亡率的非线性贡献:重新分类弗雷明汉风险类别:德黑兰血脂和血糖研究十年随访。
Int J Cardiol. 2013 Aug 20;167(4):1486-94. doi: 10.1016/j.ijcard.2012.04.053. Epub 2012 May 10.

引用本文的文献

1
A Mixed Comparisons of Different Intensities and Types of Physical Exercise in Patients With Diseases Related to Oxidative Stress: A Systematic Review and Network Meta-Analysis.不同强度和类型的体育锻炼对氧化应激相关疾病患者的混合比较:一项系统评价和网状Meta分析
Front Physiol. 2021 Aug 5;12:700055. doi: 10.3389/fphys.2021.700055. eCollection 2021.
2
Gender-Specific Independent and Combined Effects of the Cortisol-to-Cortisone Ratio and 11-Deoxycortisol on Prediabetes and Type 2 Diabetes Mellitus: From the Henan Rural Cohort Study.皮质醇-可的松比值和 11-脱氧皮质醇对糖尿病前期和 2 型糖尿病的性别特异性独立和联合影响:来自河南农村队列研究。
J Diabetes Res. 2019 Jun 2;2019:4693817. doi: 10.1155/2019/4693817. eCollection 2019.
3

本文引用的文献

1
Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.超重和肥胖伴或不伴代谢综合征与心肌梗死和缺血性心脏病。
JAMA Intern Med. 2014 Jan;174(1):15-22. doi: 10.1001/jamainternmed.2013.10522.
2
Metabolic syndrome model definitions predicting type 2 diabetes and cardiovascular disease.代谢综合征模型定义预测 2 型糖尿病和心血管疾病。
Diabetes Care. 2013 Feb;36(2):362-8. doi: 10.2337/dc11-2546. Epub 2012 Aug 29.
3
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
Metabolic syndrome predicts long-term mortality in subjects without established diabetes mellitus in asymptomatic Korean population: A propensity score matching analysis from the Korea Initiatives on Coronary Artery Calcification (KOICA) registry.
代谢综合征可预测无症状韩国人群中无确诊糖尿病患者的长期死亡率:来自韩国冠状动脉钙化倡议(KOICA)登记处的倾向评分匹配分析。
Medicine (Baltimore). 2016 Dec;95(49):e5421. doi: 10.1097/MD.0000000000005421.
4
The Antioxidant Effect of Exercise: A Systematic Review and Meta-Analysis.运动的抗氧化作用:系统评价和荟萃分析。
Sports Med. 2017 Feb;47(2):277-293. doi: 10.1007/s40279-016-0566-1.
新型风险标志物在改善中危人群心血管风险评估中的比较。
JAMA. 2012 Aug 22;308(8):788-95. doi: 10.1001/jama.2012.9624.
4
Clinically relevant measures of fit? A note of caution.临床相关的适配度衡量标准?需谨慎对待。
Am J Epidemiol. 2012 Sep 15;176(6):488-91. doi: 10.1093/aje/kws208. Epub 2012 Aug 8.
5
Interpreting incremental value of markers added to risk prediction models.解读风险预测模型中新增标志物的增量价值。
Am J Epidemiol. 2012 Sep 15;176(6):473-81. doi: 10.1093/aje/kws207. Epub 2012 Aug 8.
6
Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.基于代谢综合征的预测模型预测有临床表现的血管疾病患者的血管事件再发。
Eur J Prev Cardiol. 2012 Dec;19(6):1486-95. doi: 10.1177/1741826711426636. Epub 2011 Oct 18.
7
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.代谢综合征与心血管风险:系统评价和荟萃分析。
J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32. doi: 10.1016/j.jacc.2010.05.034.
8
Barriers to cardiovascular disease risk scoring and primary prevention in Europe.欧洲心血管疾病风险评分和一级预防的障碍。
QJM. 2010 Oct;103(10):727-39. doi: 10.1093/qjmed/hcq122. Epub 2010 Aug 4.
9
Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?一级预防中的心血管风险评估系统:它们有差异吗?它们有作用吗?我们能预见未来吗?
Circulation. 2010 Jul 20;122(3):300-10. doi: 10.1161/CIRCULATIONAHA.109.852756.
10
Cardiovascular risk prediction: basic concepts, current status, and future directions.心血管风险预测:基本概念、现状与未来方向。
Circulation. 2010 Apr 20;121(15):1768-77. doi: 10.1161/CIRCULATIONAHA.109.849166.